Skip to main content
BC Innovations
Feature Story

Funding faster diagnostics

NIAID’s $11 million step to faster diagnostics for bacterial infections

Just two weeks after the White House released its National Action Plan for Combating Antibiotic Resistant Bacteria on March 27, NIH's National Institute of Allergy and Infectious Diseases (NIAID) announced it is awarding more than $11 million in research grants for nine projects that address one of the plan's top priorities: rapid diagnosis of drug-resistant bacterial infections.

Innovation in diagnostics has not seen the boost that antibiotic therapies have in the wake of the GAIN (Generating Antibiotic Incentives Now) Act of 2012 - a fact that was highlighted at a congressional hearing held last October as part of the

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial